ular weights ranging between 280 and 800 kd. 10 The gene coding for apo(a) is located on the long arm of chromosome 6, in close proximity to the gene for plasminogen.17 '18 The location of the apo(a) gene and its high degree of homology with the plasminogen gene have prompted the hypothesis that the former derives from duplication of the plasminogen gene. 13 In addition, it has been suggested that the polymorphism in kringle 4 repeats in the apo(a) gene arises from internal recombination. This is due to the presence, in an intervening sequence of the kringle 4, of repetitive sequences involved in recombination and gene conversion in the eukaryotic genome. 19 No agreement on the definite number of apo(a) alleles in the general population has been reached. Gaubatz et a120 have reported a total of 11 apo(a) isoforms in a mixed population, whereas we have identified 12 polymorphic-size apo(a) molecules. 21 Recently, 19 apo(a) gene alleles, differing in size, have been identified by pulsed-field gel electrophoresis,19 and Kamboh et a122 have reported 24 apo(a) alleles, including a null allele.
It has been shown that Lp(a) levels are significantly higher in subjects with CAD and in subjects with stroke than in subjects free of atherosclerosis. [1] [2] [3] [4] [5] [6] [7] 23 The increased risk of CAD attributed to elevated plasma levels of Lp(a) appears to be independent of other lipoprotein parameters. However, Lp(a) may act synergistically with high levels of LDL, other risk factors, or both to increase the risk of CAD.5, 24 Elevated plasma levels of Lp(a) can be detected using electrophoretic methods,25 but immunoassay techniques have much greater precision and sensitivity.
In the present study, we have defined normal ranges for plasma levels of Lp(a) in a large caucasian population in North America that is free of symptoms of atherosclerotic disease. Our Figure 1A shows the frequency distribution of Lp(a) levels in 2,678 subjects. Although the observed range is from 0.09 to 109.2 mg/dL, the distribution is highly skewed, with 56% of the population having Lp(a) concentrations between 0 and 10 mg/dL. The frequency distribution of plasma Lp(a) levels in subjects in this range (0-10 mg/dL) is illustrated in Figure 1B . Mean plasma concentrations of Lp(a) in men and women, according to age, are reported in Table 2 . There was no significant difference between Lp(a) concentrations in men and women for any age group, although there was a trend toward an increase in plasma levels in each sex between the ages of 20 and 59 years. The concentration of Lp(a) in plasma appeared to decrease slightly in subjects more than 60 years old, with the exception of men more than 69 years old; however, the number of subjects in the latter group was very small (n= 11). Selected percentiles for plasma Lp(a) levels in men and women are shown in Table 3 . Lp(a) concentrations of more than 22 mg/dL were above the 75th percentile and values of more than 38 mg/dL were above the 90th percentile for the Framingham Offspring population, in both men and women.
When subjects of all ages (20-70+ years) were included in the analysis, there was a significant association between age and Lp(a) levels only in women (Table 4) . Total plasma cholesterol and Lp(a) levels were positively correlated in men and women (p<0.0007 and p<0.0003, respectively). Similarly, an association between LDL cholesterol and Lp(a) concentrations was observed in both sexes (p<0.0001). However, after the Lp(a) cholesterol contribution to total and LDL cholesterol levels was taken into account, these correlations were no longer statistically significant (Table 4) . A weak inverse association was also observed between triglyc- Lp(a) plasma levels were positively correlated with total cholesterol and LDL cholesterol levels in this population. The method used to calculate LDL cholesterol included Lp(a) cholesterol as well as LDL cholesterol. The positive associations between Lp(a) and total cholesterol and LDL cholesterol levels found in this 33 To rule out any triglyceride effect, we excluded subjects with triglyceride values of more than 500 mg/dL from the analyses, and the inverse correlation between Lp(a) and triglycerides remained statistically significant. A recent study reported that only about 4% of the total plasma apo(a) was found in the VLDL fraction of normal subjects in the fasted state. 47 The modest inverse correlation between Lp(a) and triglyceride levels could be due to the fact that apo(a) can be found in a variety of apo B-100-containing lipoproteins and that when it is present on triglyceride-rich lipoproteins, it can be catabolized more rapidly than when it is on regular Lp(a).
Lp(a) levels are relatively unaffected by changes in diet and by most of the medications currently used to treat hypercholesterolemia,48 with the exception of niacin. 35, 49, 50 Medications routinely used to treat metabolic disorders such as diabetes, hypertension, and thyroid dysfunction are known to have an effect on lipid metabolism. 51 There was no association in our population between use of these agents and plasma levels of Lp(a). There also was no correlation of Lp(a) with BMI, although the latter is a strong determinant of other plasma lipoproteins.52 These results support the concept that Lp(a) metabolism is largely independent of that of other lipoproteins.
At present, the data on the effects of alcohol on Lp(a) are limited and inconclusive. For example, the authors of one study53 proposed that moderate ethanol intake may lead to an increase in Lp(a), whereas other investigators54 reported a significant increase in plasma Lp(a) concentrations in alcoholic men during a 4-day period of abstention. In contrast to both of these reports, we saw no association between alcohol consumption and plasma concentrations of Lp(a).
Several studies have suggested that Lp(a) may be subject to hormonal control. Lp(a) levels Lp(a) can also compete with plasminogen for the binding to fibrin.70 It is very likely that increased plasma levels of Lp(a) interfere with the process of fibrinolytic degradation of blood clots, promoting progression of atherosclerotic lesions. Thus, it is important to set ranges for normal and elevated levels of this lipoprotein. In this study, we used an ELISA to define normal ranges in participants in the Framingham Offspring Study. According to our data, Lp(a) levels of more than 38 mg/dL are above the 90th percentile in men and women. We have previously shown that approximately 19% of subjects with CAD have Lp(a) levels above this level. 3 Moderately elevated Lp(a) levels (22-38 mg/dL) are between the 75th and 90th percentiles. Further research is needed to evaluate the risk attributable to Lp(a) levels in this range.
